Cervical cancer screening
|
Cervical cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cervical cancer screening On the Web |
|
American Roentgen Ray Society Images of Cervical cancer screening |
|
Risk calculators and risk factors for Cervical cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-in-Chief: Sarthak Sachdeva
Screening
You should start getting regular Pap tests at age 21, or within three years of the first time you have sex—which ever happens first. The Pap test is one of the most reliable and effective cancer screening tests available. It also can find other conditions that might need treatment, such as infection or inflammation. In addition to the Pap test—the main test for cervical cancer—the HPV test may be used for screening women aged 30 years and older, or women of any age who have unclear Pap test results. If you are 30 or older, and your screening tests are normal, your chance of getting cervical cancer in the next few years is very low. For that reason, your doctor may tell you that you will not need another screening test for up to three years. But you should still go to the doctor regularly for a check-up that may include a pelvic exam. It also is important for you to continue getting a Pap test regularly—even if you think you are too old to have a child, or are not having sex anymore.
Types of Screening
- Conventional cytology
- Liquid based monolayer cytology
- Human papillomavirus testing
- Tests for resource poor areas
- Visual inspection
| American Cancer Society (ACS), American Society for Colposcopy and Cervical Pathology (ASCCP), and American Society for Clinical Pathology (ASCP) | U.S. Preventive Services Task Force (USPSTF)2 2012 | American College of Obstetricians and Gynecologists (ACOG) | Society of Gynecologic Oncology (SGO) and the American Society for Colposcopy and Cervical Pathology (ASCCP): Interim clinical guidance for primary hrHPV testing | ||
| USPSTF | 2009 | Age 50-74 years: every 2 years Age 40-49 or >75: individualize decision (every 2 years if performed) |
Insufficient evidence for recommendation | Not recommended | Insufficient evidence for recommendation |
| American Cancer Society | 2010 | Age >40 years: annually | Age 20-39 years: every 3 years age >40 years: annually |
Optional | MRI annually in high risk women (20% lifetime risk of breast cancer, positive BRCA mutations, history of radiation therapy) |
| American College of Obstetricians and Gynecologists | 2011 | Age >40 years: annually | Age 20-39 years: every 3 years >40 years: annually |
Encouraged | Not recommended |
| USPSTF | 2009 | Age 50-74 years: every 2 years Age 40-49 or >75: individualize decision (every 2 years if performed) |
Insufficient evidence for recommendation | Not recommended | Insufficient evidence for recommendation |
| American Cancer Society | 2010 | Age >40 years: annually | Age 20-39 years: every 3 years age >40 years: annually |
Optional | MRI annually in high risk women (20% lifetime risk of breast cancer, positive BRCA mutations, history of radiation therapy) |
| American College of Obstetricians and Gynecologists | 2011 | Age >40 years: annually | Age 20-39 years: every 3 years >40 years: annually |
Encouraged | Not recommended
References |